Literature DB >> 21307303

Racial variation in umbilical cord blood leptin concentration in male babies.

Gabriel Y Lai1, Sabine Rohrmann, Tanya Agurs-Collins, Catherine G Sutcliffe, Gary Bradwin, Nader Rifai, Jessica L Bienstock, Elizabeth A Platz.   

Abstract

BACKGROUND: We hypothesize that racial differences in utero contribute to the racial disparity in prostate cancer risk. Leptin is a candidate for evaluating this hypothesis because it influences fetal development and newborn growth.
METHODS: We measured leptin concentration by ELISA in venous cord blood collected from 70 African-American and 37 white male full-term babies. We measured sex steroid hormones and insulin-like growth factor (IGF) axis concentrations previously. Separately by race, we calculated the geometric mean leptin concentration and estimated the geometric mean adjusted for birth and placental weights, mother's age and parity, time of day and season of birth, and sex steroid hormone and IGF axis concentrations by linear regression.
RESULTS: Leptin was positively correlated with birth (r = 0.34) and placental (r = 0.25) weights, IGF-1 (r = 0.21), and IGF binding protein-3 (r = 0.29) adjusting for race. Unadjusted geometric mean leptin did not differ (P = 0.92) between African Americans (5,280 pg/mL; 95% CI: 4,322-6,451) and whites (5,187 pg/mL; 95% CI: 3,938-6,832). Adjusted geometric mean leptin was nonstatistically significantly higher (P = 0.15) in African Americans (5,954 pg/mL; 95% CI: 4,725-7,502) than in whites (4,133 pg/mL; 95% CI: 2,890-5,910).
CONCLUSION: We observed a nonsignificantly higher adjusted cord blood leptin concentration in African-American male babies than in white male babies, although unadjusted levels were similar. IMPACT: These findings do not support the hypothesis that leptin level in utero contributes to the racial disparity in prostate cancer risk in adulthood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307303      PMCID: PMC3070060          DOI: 10.1158/1055-9965.EPI-10-0283

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  42 in total

1.  Plasma leptin is not associated with prostate cancer risk.

Authors:  Pär Stattin; Rudolf Kaaks; Robert Johansson; Randi Gislefoss; Stefan Söderberg; Henrik Alfthan; Ulf-Håkan Stenman; Egil Jellum; Tommy Olsson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

2.  Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study.

Authors:  R P Donahue; P Zimmet; J A Bean; M Decourten; R A DeCarlo Donahue; G Collier; R B Goldberg; R J Prineas; J Skyler; N Schneiderman
Journal:  Ann Epidemiol       Date:  1999-02       Impact factor: 3.797

3.  Relation of race, age, and sex hormone differences to serum leptin concentrations in children and adolescents.

Authors:  W T Ambrosius; J A Compton; R R Bowsher; J H Pratt
Journal:  Horm Res       Date:  1998

4.  Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children.

Authors:  T R Nagy; B A Gower; C A Trowbridge; C Dezenberg; R M Shewchuk; M I Goran
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

5.  Perinatal characteristics in relation to incidence of and mortality from prostate cancer.

Authors:  A Ekbom; C C Hsieh; L Lipworth; A Wolk; J Pontén; H O Adami; D Trichopoulos
Journal:  BMJ       Date:  1996-08-10

6.  Leptin in relation to prostate cancer and benign prostatic hyperplasia.

Authors:  P Lagiou; L B Signorello; D Trichopoulos; A Tzonou; A Trichopoulou; C S Mantzoros
Journal:  Int J Cancer       Date:  1998-03-30       Impact factor: 7.396

7.  High birthweight as a predictor of prostate cancer risk.

Authors:  G Tibblin; M Eriksson; S Cnattingius; A Ekbom
Journal:  Epidemiology       Date:  1995-07       Impact factor: 4.822

8.  Serum leptin concentrations and body adipose measures in older black and white adults.

Authors:  Constance E Ruhl; James E Everhart; Jingzhong Ding; Bret H Goodpaster; Alka M Kanaya; Eleanor M Simonsick; Frances A Tylavsky; Tamara B Harris
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

Review 9.  Growing evidence that several human cancers may originate in utero.

Authors:  A Ekbom
Journal:  Semin Cancer Biol       Date:  1998-08       Impact factor: 15.707

10.  Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study.

Authors:  E A Platz; E Giovannucci; E B Rimm; G C Curhan; D Spiegelman; G A Colditz; W C Willett
Journal:  Am J Epidemiol       Date:  1998-06-15       Impact factor: 4.897

View more
  5 in total

1.  Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.

Authors:  Amy L Gross; Craig J Newschaffer; Judith Hoffman-Bolton; Nader Rifai; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-07       Impact factor: 4.254

2.  Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations.

Authors:  Kari A Weber; Christopher M Heaphy; Corinne E Joshu; Jiayun Lu; Sabine Rohrmann; Jessica L Bienstock; Tanya Agurs-Collins; Alan K Meeker; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2018-07-06       Impact factor: 2.506

3.  Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.

Authors:  Steven J Dias; Xinchun Zhou; Marina Ivanovic; Michael P Gailey; Swati Dhar; Liangfen Zhang; Zhi He; Alan D Penman; Srinivasan Vijayakumar; Anait S Levenson
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

4.  Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer?

Authors:  Kari A Weber; Christopher M Heaphy; Sabine Rohrmann; Beverly Gonzalez; Jessica L Bienstock; Tanya Agurs-Collins; Elizabeth A Platz; Alan K Meeker
Journal:  Prostate Cancer       Date:  2016-12-14

Review 5.  Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis.

Authors:  Cindy Ke Zhou; Siobhan Sutcliffe; Judith Welsh; Karen Mackinnon; Diana Kuh; Rebecca Hardy; Michael B Cook
Journal:  Br J Cancer       Date:  2016-03-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.